The Penicillins and Streptomycins in Bulk Market for Luxembourg has shown a general decline in value per capita over the past decade. From a high of $1.73 in 2013, the market has dropped to $1.53 by 2023. Notable annual fluctuations occurred, with a peak growth between 2020 and 2021 of 4.27%. However, the past two years saw a year-on-year decrease of 9.94% in 2022 and a further decline in 2023. The compound annual growth rate (CAGR) over the last five years is negative, reflecting an average annual decline in market value.

Future trends to watch for include:

Impact of emerging antibiotics and generic competition on market value.
Regulatory changes within the EU that may influence drug production and distribution.
Developments in healthcare policies that could affect demand.
Technological advances in drug manufacturing potentially lowering production costs.